MARX Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 17, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,415	3,517	-	-	-
Enterprise Value	3,761	3,426	-	-	-
Last Close Price	6.75	6.93	-	-	-
PS Ratio	4.79	5.69	-	-	-
PB Ratio	15.97	14.00	-	-	-
P/TBV Ratio	29.40	22.03	-	-	-
EV/Sales Ratio	5.28	5.54	-	-	-
Debt / Equity Ratio	1.75	1.10	0.01	0.23	-
Debt / EBITDA Ratio	-	-	-	4.86	-
Debt / FCF Ratio	-	-	-	1.29	-
Net Debt / Equity Ratio	1.62	0.79	-0.51	-0.23	-0.01
Net Debt / EBITDA Ratio	-6.03	-2.80	10.61	-12.17	-
Net Debt / FCF Ratio	-0.97	-0.64	8.31	-1.29	-0.57
Asset Turnover	1.24	1.10	1.16	1.89	-
Inventory Turnover	1.32	1.61	1.84	-	-
Quick Ratio	0.37	0.66	2.53	1.99	0.27
Current Ratio	1.16	1.32	3.40	2.32	0.27
Return on Equity (ROE)	-36.09%	-35.58%	-7.30%	7.66%	-
Return on Assets (ROA)	-8.02%	-9.44%	-4.24%	0.96%	-
Return on Invested Capital (ROIC)	-13.15%	-28.69%	-17.88%	1.41%	-6.42%
Return on Capital Employed (ROCE)	-18.80%	-20.10%	-5.70%	1.50%	-6.30%
Earnings Yield	-2.43%	-2.75%	-	-	-
FCF Yield	-10.43%	-8.91%	-	-	-
Payout Ratio	-	-	-	259.63%	-
Buyback Yield / Dilution	-31.29%	-55.49%	7.99%	-982.64%	-
Total Shareholder Return	-31.29%	-55.49%	7.99%	-982.64%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.